Analysis of Revascularization in Ischemic Stroke With EmboTrap
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 228 participants.
Also called NCT02488915
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 228 participants
- Sponsor
- Neuravi Inc.
- Registry
-
NCT02488915
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Belgium, Germany, Ireland
- Registry status
- Completed
Technical summary
Registry record NCT02488915. Allocation not applicable; no masking; primary purpose treatment. Start 2015-11 (actual); primary completion 2017-05 (actual). Results posted on 2018-07-13.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Analysis of Revascularization in Ischemic Stroke With EmboTrap
- Acronym
- ARISEII
- Condition
- Stroke
- Condition
- Ischemia
- Intervention (Device)
- EmboTrap® Revascularization Device
- Lead sponsor
- Neuravi Inc.
Record details
- Record id
cardio:ct-nct02488915- Content hash
bdc9c2e1b125004199f208c83e9658dab113b06f644c4fd893f952af7da0c36a